Shiran Konganige
Papers
1
Total Citations
1
H-Index
1
About
Shiran Konganige is a rising urologic oncology researcher whose work focuses on optimizing treatment strategies for recurrent prostate cancer. Her most-cited study, "The outcomes of salvage robotic radical prostatectomy following radiation versus focal therapy: Does the primary treatment modality matter?" (2025), makes a critical contribution to the field by comparing salvage robotic radical prostatectomy (sRRP) outcomes after two distinct primary treatments: radiation therapy and focal therapy. This research addresses a pressing clinical question—whether the initial treatment modality influences surgical and oncologic results in the salvage setting. By analyzing perioperative findings, Konganige provides evidence that can guide urologists in selecting the most appropriate salvage approach for patients with recurrent disease. Though early in her career, with her work already garnering attention, Konganige is establishing herself as a thoughtful investigator in prostate cancer management. Her focus on salvage therapies and comparative effectiveness research promises to improve decision-making for patients facing recurrence after initial treatment, making her a researcher to watch in the evolving landscape of prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1